Showing results (841-850 of 855) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|February 9, 2024
Transplantation and Cellular Therapy for Older Adults-The MSK ApproachRichard J Lin, Parastoo B Dahi, Beatriz Korc-Grodzicki, et al.Current Hematologic Malignancy Reports|February 23, 2024
Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Strategies to Optimize Success and New DirectionsDelphine Rea, Sofiane Fodil, Etienne Lengline, et al.Current Hematologic Malignancy Reports|March 7, 2024
Update on T-Cell Lymphoma EpidemiologyJane J Chen, Franco Castillo Tokumori, Christina Del Guzzo, et al.Current Hematologic Malignancy Reports|July 6, 2024
Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström MacroglobulinemiaKaran L Chohan, Prashant KapoorCurrent Hematologic Malignancy Reports|July 22, 2024
Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicalsJohannes Lübke, Georgia Metzgeroth, Andreas Reiter, et al.Current Hematologic Malignancy Reports|February 1, 2024
How Do We Manage Chronic Lymphocytic Leukemia in IndiaParathan Karunakaran, Nidhi Jain, Deepesh P LadCurrent Hematologic Malignancy Reports|August 23, 2024
Prognostic and Predictive Models in MyelofibrosisBarbara Mora, Cristina Bucelli, Daniele Cattaneo, et al.Current Hematologic Malignancy Reports|October 14, 2024
JAK Inhibitors for Myelofibrosis: Strengths and LimitationsK Thaw, C N Harrison, P SriskandarajahCurrent Hematologic Malignancy Reports|August 15, 2024
Management of Toxicities Associated with BCMA, GPRC5D, and FcRH5-Targeting Bispecific Antibodies in Multiple MyelomaDarren Pan, Joshua RichterCurrent Hematologic Malignancy Reports|October 19, 2024
Maintenance Therapy Post-Stem Cell Transplantation for Patients with T-Cell LymphomasZachary Braunstein, Jonathan E BrammerPageof 86